• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚人中S-美芬妥因羟基化表型与CYP2C19基因型

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.

作者信息

Persson I, Aklillu E, Rodrigues F, Bertilsson L, Ingelman-Sundberg M

机构信息

Faculty of medicine, Addis Ababa University, Ethiopia.

出版信息

Pharmacogenetics. 1996 Dec;6(6):521-6. doi: 10.1097/00008571-199612000-00005.

DOI:10.1097/00008571-199612000-00005
PMID:9014201
Abstract

The polymorphic metabolism of S-mephenytoin and the distribution of two known deleterious mutant CYP2C19 alleles was determined among 114 healthy unrelated black Ethiopians. Six subjects (5.2%) were poor metabolizers (PMs) of S-mephenytoin. The frequencies of the defective CYP2C192 (CYP2C19m1) and CYP2C193 (CYP2C19m2) alleles were 0.14 and 0.02, respectively. Three of the PMs were homozygous for the CYP2C192 allele and the remaining three PMs were heterozygous for both the CYP2C192 and CYP2C193 mutant alleles. It is concluded that the frequency of PMs for S-mephenytoin is similar in Ethiopians, Zimbabweans and Caucasians and that the CYP2C193 allele, for the first time identified in a black population, together with the CYP2C19*2 allele account for all of the defective CYP2C19 alleles among the Ethiopian PMs.

摘要

在114名健康、无血缘关系的埃塞俄比亚黑人中,测定了S-美芬妥因的多态性代谢以及两种已知有害突变CYP2C19等位基因的分布情况。6名受试者(5.2%)为S-美芬妥因的慢代谢者(PMs)。缺陷型CYP2C192(CYP2C19m1)和CYP2C193(CYP2C19m2)等位基因的频率分别为0.14和0.02。其中3名慢代谢者为CYP2C192等位基因纯合子,其余3名慢代谢者为CYP2C192和CYP2C193突变等位基因杂合子。得出的结论是,埃塞俄比亚人、津巴布韦人和高加索人中S-美芬妥因慢代谢者的频率相似,并且首次在黑人人群中鉴定出的CYP2C193等位基因,与CYP2C19*2等位基因一起,构成了埃塞俄比亚慢代谢者中所有缺陷型CYP2C19等位基因。

相似文献

1
S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.埃塞俄比亚人中S-美芬妥因羟基化表型与CYP2C19基因型
Pharmacogenetics. 1996 Dec;6(6):521-6. doi: 10.1097/00008571-199612000-00005.
2
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype.奥美拉唑作为瑞典高加索人群中CYP2C19表型的探针药物的应用:与S-美芬妥因羟化表型及CYP2C19基因型的比较
Pharmacogenetics. 1995 Dec;5(6):358-63. doi: 10.1097/00008571-199512000-00004.
3
CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population.中国傣族人群中CYP2C19基因型与S-美芬妥因4'-羟化代谢表型
Eur J Clin Pharmacol. 2002 Apr;58(1):15-8. doi: 10.1007/s00228-002-0425-x. Epub 2002 Feb 22.
4
Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese.在日本人中,可通过CYP2C19单倍型识别出(S)-美芬妥因代谢不良者的证据。
Pharmacogenetics. 1996 Jun;6(3):265-7. doi: 10.1097/00008571-199606000-00011.
5
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations.在不同的东方、高加索、沙特阿拉伯和美国黑人人群中,导致美芬妥英慢代谢者表型的CYP2C19缺陷等位基因的频率。
Pharmacogenetics. 1997 Feb;7(1):59-64. doi: 10.1097/00008571-199702000-00008.
6
Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.中国汉族和白族人群中影响S-美芬妥英代谢表型的CYP2C19基因多态性发生率差异及一种新的罕见CYP2C19突变等位基因的鉴定
J Pharmacol Exp Ther. 1997 Apr;281(1):604-9.
7
Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent.非洲裔人群中(S)-美芬妥因4'-羟化的基因多态性。
Br J Clin Pharmacol. 1999 Sep;48(3):402-8. doi: 10.1046/j.1365-2125.1999.00009.x.
8
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.鉴定一种导致日本人中(S)-美芬妥因代谢多态性的新基因缺陷。
Mol Pharmacol. 1994 Oct;46(4):594-8.
9
Genetic analysis of the S-mephenytoin polymorphism in a Chinese population.中国人群中S-美芬妥英多态性的遗传分析。
Clin Pharmacol Ther. 1995 Oct;58(4):404-11. doi: 10.1016/0009-9236(95)90053-5.
10
CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population.
Pharmacogenetics. 1996 Aug;6(4):329-39. doi: 10.1097/00008571-199608000-00006.

引用本文的文献

1
A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications.心血管疾病药物遗传学研究进展及其对临床意义影响的叙述性综述
NPJ Genom Med. 2025 Jul 10;10(1):54. doi: 10.1038/s41525-025-00511-6.
2
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt.埃及经皮冠状动脉介入治疗后服用氯吡格雷的缺血性心脏病患者 CYP2C19 多态性。
J Epidemiol Glob Health. 2023 Jun;13(2):374-383. doi: 10.1007/s44197-023-00113-4. Epub 2023 May 18.
3
CYP2C19 gene polymorphism in Ningxia.
宁夏 CYP2C19 基因多态性。
Pharmacol Rep. 2023 Jun;75(3):705-714. doi: 10.1007/s43440-023-00473-5. Epub 2023 Mar 13.
4
Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome gene in six major ethnicities of Pakistan.评估巴基斯坦六个主要民族的药物代谢酶细胞色素基因的多态性。
Bioengineered. 2021 Dec;12(1):4442-4451. doi: 10.1080/21655979.2021.1955809.
5
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?药物代谢和转运体遗传学如何为精神药物处方提供信息?
Front Genet. 2020 Dec 8;11:491895. doi: 10.3389/fgene.2020.491895. eCollection 2020.
6
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.药物遗传学研究中种族和民族分类的不一致性及其潜在的临床意义。
Pharmgenomics Pers Med. 2019 Jul 2;12:107-123. doi: 10.2147/PGPM.S207449. eCollection 2019.
7
Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients.在中国接受氯吡格雷治疗的患者中,CYP2C19和ABCB1基因多态性与氯吡格雷抵抗之间的关联。
Anatol J Cardiol. 2018 Feb;19(2):123-129. doi: 10.14744/AnatolJCardiol.2017.8097. Epub 2018 Jan 19.
8
Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (‑806 C>T) alleles among an Iranian population of different ethnicities.伊朗不同种族人群中 CYP2C19*2(681 G>A)、*3(636 G>A)和*17(-806 C>T)等位基因的流行率。
Mol Med Rep. 2018 Mar;17(3):4195-4202. doi: 10.3892/mmr.2018.8377. Epub 2018 Jan 5.
9
Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China.中国南方一个大型客家人群 CYP2C19 基因多态性分析。
Med Sci Monit. 2017 Dec 30;23:6186-6192. doi: 10.12659/msm.905337.
10
Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.藏族人群中CYP2C19的基因型-表型分析及其在药物治疗中的潜在临床意义。
Mol Med Rep. 2016 Mar;13(3):2117-23. doi: 10.3892/mmr.2016.4776. Epub 2016 Jan 13.